Jia Jie Biomedical Co., Ltd. (TPEX:4109)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
11.65
+0.20 (1.75%)
Apr 29, 2026, 1:30 PM CST
-29.82%
Market Cap 1.36B
Revenue (ttm) 485.40M
Net Income (ttm) 50.26M
Shares Out 118.74M
EPS (ttm) 0.43
PE Ratio 26.63
Forward PE n/a
Dividend 0.20 (1.75%)
Ex-Dividend Date n/a
Volume 146,856
Average Volume 208,589
Open 11.35
Previous Close 11.45
Day's Range 11.35 - 11.70
52-Week Range 11.30 - 18.80
Beta 0.06
RSI 22.96
Earnings Date Apr 2, 2026

About Jia Jie Biomedical

Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules; and import and export, distribution, bidding, quotation of the products. It also involved in the wholesa... [Read more]

Industry Packaged Foods
Founded 1995
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4109
Full Company Profile

Financial Performance

In 2025, Jia Jie Biomedical's revenue was 485.40 million, a decrease of -9.62% compared to the previous year's 537.07 million. Earnings were 50.26 million, a decrease of -76.22%.

Financial Statements

News

There is no news available yet.